Cell Source Inc Stock OTC Bulletin Board
Equities
US15114L1044
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 29.96M |
---|---|---|---|---|---|
Net income 2021 | -5M | Net income 2022 | -5M | EV / Sales 2021 | - |
Net Debt 2021 | 6.4M | Net Debt 2022 | 7.68M | EV / Sales 2022 | - |
P/E ratio 2021 |
-6.58
x | P/E ratio 2022 |
-4.68
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 70.08% |
Managers | Title | Age | Since |
---|---|---|---|
Itamar Shimrat
CEO | Chief Executive Officer | 63 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Brown
CHM | Chairman | 74 | 14-06-29 |
Itamar Shimrat
CEO | Chief Executive Officer | 63 | - |
Darlene Soave
BRD | Director/Board Member | 80 | 21-03-24 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |